Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. ...

In the latest trading session, Amgen (AMGN) closed at $355.25, marking a -1.44% move from the previous day. The stock's ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

ERAS-0015 Phase 1 data, valuation gap, Merck deal, funding, and key risks like patents. Click for more on ERAS stock.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

Stock Market Today: The Dow Jones index drops Friday as oil prices rise. Nasdaq dives as Netflix stock sinks on soft guidance ...

Pfizer (NYSE: PFE) and Amgen (NASDAQ: AMGN) both reported Q1 2026 results this quarter, and the numbers reveal two very ...

After moving mostly higher over the two previous sessions, stocks are giving back some ground during trading on Thursday. The ...

Second-quarter earnings season is gaining momentum, with investors looking beyond quarterly results to companies with strong ...

There are good reasons to invest in Lilly and to hold off.

Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its second-quarter ...

The weight-loss boom has created one of the market's biggest opportunities — and some of its most punishing failures.